vaccin
work
elicit
immun
respons
consequ
immunolog
memori
mediat
protect
infect
diseas
recent
new
method
develop
dissect
immun
respons
experiment
anim
human
led
increas
understand
molecular
mechan
control
differenti
mainten
memori
b
cell
review
provid
overview
cellular
organ
immun
memori
underlin
outstand
question
immunolog
memori
pertain
vaccin
strategi
final
discuss
learn
antigen
design
interrog
memori
b
cell
journey
vaccin
memori
back
immunolog
memori
abil
immun
system
respond
greater
vigor
upon
reencount
pathogen
constitut
basi
vaccin
ahm
gray
fact
concept
vaccin
origin
sever
hundr
year
ago
histor
observ
date
far
back
bc
individu
surviv
diseas
rare
got
diseas
second
time
finley
jr
plotkin
plotkin
first
record
attempt
immun
occur
th
centuri
process
variol
use
prevent
smallpox
involv
inject
smallpox
pustul
infect
patient
healthi
individu
remark
first
attempt
immun
predat
knowledg
microbiolog
immunolog
janeway
et
al
major
breakthrough
vaccin
came
jenner
use
cowpox
vaccin
smallpox
worth
note
landmark
work
jenner
also
root
concept
memori
sinc
astut
observ
milkmaid
gotten
cowpox
spare
ravag
smallpox
janeway
et
al
plotkin
plotkin
vaccin
remain
effect
method
prevent
infecti
diseas
repres
relev
contribut
immunolog
human
health
siegrist
phenomen
success
vaccin
polio
smallpox
measl
diphtheria
tetanu
rabi
etc
demonstr
potenti
approach
reduc
global
burden
infecti
diseas
case
smallpox
complet
erad
scourg
use
kill
disfigur
signific
popul
world
breman
arita
howev
despit
remark
success
major
challeng
still
remain
urgent
need
develop
vaccin
import
human
pathogen
hiv
mycobacterium
tuberculosi
plasmodium
falciparum
hcv
rsv
dengu
viru
hall
hill
houghton
abrignani
johnston
fauci
langhorn
et
al
mcmichael
et
al
skeiki
sadoff
walker
burton
whitehead
et
al
addit
vaccin
fight
cancer
autoimmun
diseas
highli
sought
goal
repres
excit
new
area
vaccin
research
develop
larch
wraith
lollini
et
al
melief
van
der
burg
review
discuss
studi
immunolog
memori
defin
metric
qualiti
specif
immun
respons
may
provid
ration
approach
vaccin
develop
accordingli
articl
divid
three
section
first
part
provid
overview
cellular
organ
immun
memori
second
part
consid
outstand
question
immunolog
memori
protect
immun
pertain
vaccin
strategi
last
section
discuss
learn
memori
b
cell
process
go
back
memori
vaccin
design
memori
b
cell
progeni
antigen
specif
cell
clonal
expand
cours
immun
respons
surviv
antigen
elimin
memori
cell
confer
immedi
protect
gener
secondari
respons
rapid
higher
magnitud
compar
primari
respons
tabl
b
cell
system
immedi
protect
mediat
longliv
plasma
cell
present
bone
marrow
secret
antibodi
antigenindepend
fashion
thu
maintain
constant
level
serum
bodi
fluid
radbruch
et
al
recal
respons
mediat
memori
b
cell
rapidli
prolifer
differenti
respons
antigen
stimul
gener
burst
plasma
cell
mark
transient
elev
serum
antibodi
similar
divis
labor
appli
cell
system
sallusto
et
al
immedi
protect
confer
circul
tissu
resid
effector
memori
cell
em
survey
frontlin
barrier
diseas
tissu
incom
pathogen
display
immedi
effector
function
upon
antigen
recognit
recal
respons
mediat
central
memori
cell
cm
patrol
cell
area
secondari
lymphoid
tissu
rapidli
prolifer
respons
antigen
present
dendrit
cell
dc
divis
labor
implic
vaccin
strategi
sinc
protect
infect
diseas
may
reli
primarili
either
mechan
depend
natur
pathogen
size
rout
challeng
instanc
preform
antibodi
long
live
plasma
cell
requir
neutral
toxin
prevent
infect
incom
viru
recal
respons
mediat
cm
memori
b
cell
may
suffici
protect
virus
long
incub
time
qualiti
amount
memori
cell
set
antigendriven
primari
immun
respons
initi
cell
area
secondari
lymphoid
organ
rare
antigenspecif
cell
stimul
antigen
present
activ
dc
pathogen
activ
dc
trigger
multipl
innat
receptor
either
directli
via
pathogen
associ
molecular
pattern
pamp
indirectli
via
danger
associ
molecular
pattern
damp
lead
enhanc
antigen
present
costimul
product
polar
cytokin
iwasaki
medzhitov
natur
combin
innat
receptor
trigger
dc
determin
capac
imprint
differ
fate
prolifer
cell
reiner
et
al
respons
certain
virus
intracellular
pathogen
dc
produc
promot
differenti
cell
capabl
produc
effect
pathogen
macatonia
et
al
likewis
respons
fungi
certain
bacteria
dc
monocyt
produc
drive
differenti
cell
secret
recruit
neutrophil
mediat
protect
extracellular
pathogen
acostarodriguez
et
al
protect
natur
polar
respons
underlin
studi
human
immunodefici
patient
defect
respons
suffer
mycobacteri
fungal
infect
respect
et
al
milner
et
al
complex
pathway
trigger
helminth
allergen
involv
epitheli
cell
innat
natur
helper
cell
appear
control
induct
cell
produc
mediat
protect
allergi
coffman
effector
memori
helper
cell
subset
recent
character
mice
human
veldhoen
et
al
trifari
et
al
may
involv
allergi
skin
defens
respect
cell
act
directli
promot
differ
type
inflammatori
respons
tissu
also
play
essenti
role
b
cell
cell
respons
dedic
subset
follicular
helper
cell
fh
requir
induct
germin
center
reaction
lead
differenti
memori
b
cell
long
live
plasma
cell
secret
high
affin
antibodi
switch
isotyp
vinuesa
et
al
fh
cell
produc
differenti
depend
kassioti
ogarra
high
avid
interact
antigen
specif
b
cell
fazilleau
et
al
qi
et
al
helper
cell
also
promot
dc
matur
via
interact
way
help
gener
effector
memori
cell
poorli
immunogen
antigen
protein
antigen
lanzavecchia
context
vaccin
design
detail
studi
aim
defin
one
hand
pattern
express
innat
receptor
mice
human
cytokin
cue
drive
differenti
differ
effector
cell
subset
qualiti
cell
respons
profoundli
influenc
pamp
damp
also
natur
dc
present
antigen
tissu
microenviron
cell
respons
take
place
distinct
subset
mous
dc
process
present
exogen
antigen
mhc
class
molecul
crossprim
ctl
respons
heath
carbon
dc
similar
properti
recent
describ
human
villadango
shortman
gut
skin
deriv
dc
imprint
express
skin
gut
home
receptor
differenti
cell
sigmundsdottir
butcher
monocyt
repres
abund
heterogen
popul
circul
cell
rapidli
recruit
site
inflamm
immun
respons
differenti
dc
auffray
et
al
import
studi
address
role
differ
dc
monocyt
subset
cell
respons
overemphas
view
possibl
target
antigen
vaccin
differ
cell
type
vivo
bonifaz
et
al
kamphorst
et
al
b
cell
respons
protein
antigen
highli
orchestr
process
initi
boundari
b
cell
area
cell
prime
antigenpres
dc
encount
specif
b
cell
captur
process
nativ
antigen
relay
macrophag
line
subcapsular
sinu
phan
et
al
antigenspecif
tb
interact
lead
rapid
expans
differenti
b
cell
short
live
plasma
cell
produc
unmut
igm
antibodi
extrafollicular
respons
follow
format
germin
center
reaction
fh
cell
antigen
trap
follicular
dendrit
cell
fdc
network
drive
prolifer
isotyp
switch
affin
matur
antigenspecif
b
cell
lead
gener
memori
b
cell
longliv
plasma
cell
produc
high
affin
somat
mutat
antibodi
switch
isotyp
allen
et
al
durat
germin
center
reaction
may
vari
depend
natur
antigen
may
last
sever
week
month
impli
high
affin
antibodi
memori
cell
gener
well
elimin
pathogen
dogan
et
al
unlik
protein
antigen
elicit
tdepend
b
cell
respons
bacteri
polysaccharid
trigger
tindepend
b
cell
respons
result
gener
short
live
plasma
cell
without
memori
cell
repeat
stimul
polysaccharid
lead
progress
decreas
respons
eventu
exhaust
specif
b
cell
pollard
et
al
contrast
polysaccharid
conjug
protein
antigen
elicit
tdepend
b
cell
respons
memori
b
cell
effect
boost
glycoconjug
approach
success
use
develop
highli
effect
conjug
vaccin
pneumococcu
meningococcu
human
larg
fraction
circul
b
cell
igm
carri
somat
mutat
ig
gene
current
unclear
whether
cell
repres
circul
equival
mous
margin
zone
b
cell
respond
blood
born
pathogen
popul
bona
fide
memori
cell
seifert
kupper
weill
et
al
recent
use
mous
model
aiddepend
memori
b
cell
label
shown
b
cell
memori
appear
igm
b
cell
found
germin
center
well
outsid
b
cell
follicl
challeng
igg
subset
differenti
plasma
cell
wherea
igm
subset
reiniti
germin
center
reaction
suggest
dogan
et
al
find
translat
human
system
import
implic
monitor
vaccin
dissect
immedi
antibodi
respons
germin
center
depend
secondari
respons
small
fraction
expand
cell
present
peak
immun
respons
surviv
memori
cell
mice
precursor
memori
cell
could
identifi
hi
cell
abund
hi
cell
shown
repres
short
live
effector
cell
joshi
et
al
kaech
et
al
kaech
wherri
sarkar
et
al
appear
ratio
effector
memori
precursor
set
differenti
express
transcript
factor
tbet
eomesodermin
turn
depend
strength
stimul
antigen
cytokin
wnt
signal
gattinoni
et
al
intlekof
et
al
use
method
analyz
progeni
singl
cell
recent
shown
within
singl
clone
cell
adopt
multipl
fate
includ
differ
type
effector
memori
cell
individu
naiv
cell
express
high
low
avid
tcr
yield
effector
memori
cell
gerlach
et
al
stemberg
et
al
memori
b
cell
well
long
live
plasma
cell
maintain
rel
constant
number
absenc
elicit
antigen
virtual
lifetim
surviv
depend
exogen
cytokin
avail
distinct
nich
determin
size
memori
pool
memori
cell
surviv
cytokin
maintain
cell
state
slow
continu
prolifer
surh
sprent
memori
b
cell
also
divid
low
rate
surviv
cytokin
yet
defin
although
shown
intact
bcr
phospholipas
requir
long
term
mainten
function
hikida
et
al
contrast
long
live
plasma
cell
surviv
without
divid
bone
marrow
nich
organ
stromal
cell
provid
associ
cell
surviv
cytokin
april
radbruch
et
al
unlik
memori
cell
elabor
cytokin
respons
antigen
stimul
long
live
plasma
cell
continu
produc
antibodi
thu
maintain
serum
level
constant
bone
marrow
also
contain
memori
cell
may
recircul
di
rosa
pabst
well
recent
describ
popul
sessil
rest
memori
cell
occupi
distinct
nich
contact
produc
stromal
cell
tokoyoda
et
al
fact
termin
differenti
effector
memori
cell
em
plasma
cell
reduc
prolif
reconstitut
capac
led
hypothesi
long
term
mainten
memori
cell
would
depend
cell
retain
prolif
capac
cm
memori
b
cell
even
special
subset
memori
stem
cell
lanzavecchia
sallusto
case
cell
model
support
find
longterm
reconstitut
capac
characterist
cm
rather
em
cell
prospect
isol
put
memori
stem
cell
gattinoni
et
al
turtl
et
al
recent
studi
identifi
signal
pathway
appear
involv
differenti
memori
stem
cell
well
drug
favor
gener
cm
cell
araki
et
al
gattinoni
et
al
pearc
et
al
much
debat
role
antigen
maintain
memori
clear
care
done
cell
transfer
experi
employ
varieti
model
system
memori
b
cell
persist
absenc
antigen
gray
hou
et
al
lau
et
al
zinkernagel
find
extend
show
memori
cell
persist
even
absenc
restrict
mhc
molecul
muralikrishna
et
al
swain
et
al
howev
antigen
persist
gc
play
import
role
select
matur
b
cell
respons
data
suggest
antigenantibodi
complex
persist
follicular
dendrit
cell
extend
period
time
antigen
may
play
role
shape
b
cell
repertoir
chen
et
al
tew
et
al
interestingli
sustain
high
level
solubl
antigen
often
lead
induct
toler
exhaust
b
cell
case
certain
chronic
viral
infect
antigen
specif
b
cell
express
varieti
inhibitori
receptor
result
function
exhaust
cell
barber
et
al
virgin
et
al
wherri
et
al
past
decad
consider
interest
defin
global
gene
express
profil
memori
b
cell
hain
wherri
kaech
wherri
staal
clever
approach
highli
inform
sinc
provid
unbias
look
gene
regul
memori
differenti
particularli
valuabl
studi
perform
integr
genom
analysi
antigen
specif
cell
progress
effector
memori
transit
kaech
et
al
longitudin
studi
identifi
key
gene
transcript
factor
surviv
molecul
cytokin
chemokin
receptor
home
signal
molecul
etc
differenti
express
memori
cell
also
provid
insight
mechan
memori
format
defin
signatur
effector
memori
cell
gene
profil
studi
also
provid
insight
mechan
cell
dysfunct
chronic
infect
identifi
key
inhibitori
receptor
express
exhaust
virusspecif
cell
barber
et
al
wherri
et
al
b
cell
may
differenti
directli
shortliv
plasma
cell
may
pass
germin
center
reaction
becom
either
memori
b
cell
longliv
plasma
cell
gene
express
pattern
associ
transit
analyz
sever
group
use
dna
microarray
alizadeh
et
al
bhattacharya
et
al
good
et
al
good
tangy
jourdan
et
al
klein
et
al
tart
et
al
tomayko
et
al
underhil
et
al
vinuesa
et
al
differenti
b
cell
either
germin
center
b
cell
plasma
cell
accompani
major
chang
gene
regul
driven
master
transcript
factor
less
known
gene
express
differ
distinguish
shortfrom
longliv
plasma
cell
gene
express
signatur
longliv
plasma
cell
isol
human
bone
marrow
recent
compar
shortliv
plasma
cell
deriv
vitro
stimul
memori
b
cell
jourdan
et
al
studi
show
bone
marrow
plasma
cell
display
reduc
express
proapopt
molecul
fa
well
downregul
molecul
involv
lymphocyt
traffick
thu
appear
bone
marrow
plasma
cell
display
resist
apoptosi
reduc
abil
traffic
anatom
site
detail
studi
defin
signatur
longliv
versu
shortliv
plasma
cell
use
develop
vaccin
induc
longterm
humor
immun
previou
section
given
overview
cellular
organ
immunolog
memori
consid
key
question
memori
protect
immun
pertain
develop
next
gener
vaccin
remark
success
vaccin
come
mostli
acut
infect
caus
invari
pathogen
howev
lack
effect
vaccin
pathogen
highli
variabl
andor
caus
persist
latent
infect
hiv
hcv
tuberculosi
houghton
abrignani
johnston
fauci
mcmichael
et
al
skeiki
sadoff
walker
burton
also
proven
difficult
develop
success
vaccin
acut
infect
rsv
malaria
natur
infect
result
complet
protect
reinfect
case
vaccin
trump
natur
hall
hill
langhorn
et
al
develop
effect
vaccin
import
human
diseas
present
uniqu
set
challeng
pathogen
articl
issu
immun
deal
specif
hiv
tb
malaria
vaccin
howev
also
fundament
concept
immun
memori
vaccin
cut
across
differ
pathogen
consid
key
issu
start
brief
gener
discuss
protect
immun
correl
vaccin
efficaci
consider
interest
debat
determin
rel
import
b
cell
respons
protect
immun
ahm
gray
ahm
et
al
appay
et
al
examin
issu
one
must
rememb
antibodi
cell
evolv
perform
distinct
function
busi
antibodi
deal
microb
ie
free
viru
particl
bacteria
parasit
cell
deal
infect
cell
sinc
cell
recogn
microbi
antigen
associ
host
mhc
molecul
free
viru
particl
bacteria
invis
thu
antibodi
provid
specif
defens
free
microbi
organ
import
preexist
antibodi
protect
immun
infecti
diseas
overemphas
fact
antibodi
like
sole
mechan
protect
immun
bacteria
parasit
exclus
extracellular
lifestyl
situat
rel
easi
determin
correl
vaccin
efficaci
base
level
serum
antibodi
pathogen
toxin
siegrist
howev
equat
begin
chang
virus
bacteria
parasit
surviv
replic
intracellularli
although
antibodi
provid
first
line
defens
infect
antibodi
level
use
correl
vaccin
efficaci
sever
viral
vaccin
influenza
viru
yellow
fever
viru
siegrist
often
situat
inoculum
neutral
opson
preexist
antibodi
cell
come
play
either
kill
infect
cell
andor
releas
cytokin
inhibit
growth
microb
impair
abil
pathogen
surviv
insid
cell
exampl
cell
immun
accur
correl
efficaci
zoster
vaccin
levin
defin
correl
vaccin
efficaci
pathogen
vari
go
much
challeng
sinc
mechan
protect
immun
may
vari
depend
upon
viral
strain
individu
expos
like
newer
approach
need
defin
correl
tradit
method
use
singl
paramet
determin
vaccin
efficaci
simpli
go
work
difficult
vaccin
consider
excit
prospect
use
system
biolog
approach
defin
correl
vaccin
efficaci
see
review
pulendran
et
al
issu
howev
even
may
suffici
perhap
solut
lie
combin
system
biolog
approach
novel
method
assess
quantiti
also
qualiti
memori
b
cell
respons
one
fascin
thing
immun
system
abil
lymphocyt
sens
number
takada
jameson
homeostat
regul
quit
cell
specif
b
cell
sens
cell
also
specif
count
versu
cell
exampl
cell
deplet
select
expans
cell
cell
fill
compart
vice
versa
upon
reduct
cell
mechan
sens
known
abil
immun
system
count
import
implic
vaccin
convent
wisdom
size
immun
system
includ
number
memori
cell
fix
new
memori
cell
gener
upon
infect
vaccin
must
eros
preexist
memori
cell
make
room
new
one
freita
rocha
goldrath
welsh
et
al
principl
correct
known
fix
ceil
much
flexibl
exist
accommod
new
memori
cell
recent
studi
address
critic
issu
shown
size
total
memori
cell
pool
mice
almost
doubl
accommod
new
cell
minim
attrit
preexist
memori
cell
vezi
et
al
interest
increas
occur
almost
exclus
effector
memori
cell
suggest
memori
cell
subset
adapt
host
accord
immunolog
experi
context
worth
note
larg
number
hcmv
ebv
specif
effector
memori
cell
accumul
human
time
klenerman
hill
instanc
increas
strike
cell
specif
singl
hcmv
epitop
account
total
cell
respons
well
document
studi
mice
human
percentag
cell
declin
age
wherea
percentag
memori
cell
increas
linton
dorshkind
nikolichzugich
assum
revers
ratio
versu
memori
cell
entir
due
loss
cell
reflect
decreas
thymic
output
function
age
howev
rigor
rule
observ
chang
ratio
also
due
increas
number
memori
cell
result
increas
immunolog
experi
time
issu
need
address
detail
quantit
memori
cell
number
lymphoid
nonlymphoid
tissu
use
murin
well
nonhuman
primat
model
anoth
import
question
deserv
attent
determin
sens
number
memori
cell
word
immun
system
count
total
number
cell
irrespect
whether
memori
memori
cell
number
regul
independ
understand
issu
signific
implic
design
vaccin
approach
b
cell
system
also
homeostat
control
mechan
regul
memori
b
cell
number
well
total
immunoglobulin
level
serum
nimmerjahn
ravetch
sanz
et
al
better
understand
underli
regulatori
mechan
need
particular
issu
plasma
cell
homeostasi
critic
vaccin
induc
protect
immun
vaccin
induc
antibodi
maintain
serum
extend
period
longliv
plasma
cell
resid
bone
marrow
constitut
produc
antibodi
absenc
antigen
amanna
et
al
manz
et
al
slifka
et
al
believ
bone
marrow
environ
particularli
conduc
provid
necessari
surviv
signal
plasma
cell
manz
et
al
oconnor
et
al
import
determin
competit
surviv
nich
bone
marrow
impact
vaccin
induc
immun
critic
question
mani
plasma
cell
bone
marrow
accommod
certain
type
plasma
cell
compet
better
surviv
nich
defin
characterist
cell
plasma
cell
gener
answer
question
provid
ration
approach
develop
vaccin
induc
longterm
antibodi
respons
immun
system
evolv
two
line
defens
pathogen
tabl
first
line
defens
consist
preform
mucos
antibodi
iga
igg
effector
memori
cell
present
portal
pathogen
entri
addit
serum
antibodi
also
provid
import
first
line
defens
pathogen
initi
infect
blood
second
line
defens
consist
memori
b
cell
present
lymphoid
tissu
cell
prolifer
differenti
effector
cell
migrat
site
infect
note
memori
cell
lymphoid
tissu
also
elabor
effector
function
rapidli
much
faster
cell
import
immedi
protect
limit
delay
reach
site
infect
consequ
critic
differ
cm
em
much
speed
becom
effector
actual
anatom
locat
inabl
cm
provid
immedi
protect
mucos
site
compens
abil
prolifer
gener
larg
pool
effector
cell
critic
limit
spread
infect
eventu
clearanc
pathogen
thu
ideal
vaccin
induc
mucos
well
system
immun
provid
first
second
line
defens
infect
diseas
howev
hit
run
pathogen
infect
mucos
site
caus
clinic
symptom
within
ex
rotaviru
noroviru
enter
bacteria
etc
essenti
effect
mucos
immun
first
line
defens
also
import
virus
like
hiv
establish
latent
infect
initi
acquisit
block
consider
progress
made
identifi
home
molecul
b
cell
util
tissu
entri
tabl
particular
interest
mucos
immun
home
receptor
lymphocyt
use
migrat
gut
genit
tract
respiratori
tract
three
major
site
pathogen
entri
import
question
well
understood
receptor
imprint
activ
b
cell
knowledg
har
develop
vaccin
induc
effect
mucos
immun
sever
studi
shown
express
specif
home
receptor
coupl
locat
activ
exampl
prime
cell
mesenter
lymph
node
induc
express
need
migrat
gut
wherea
prime
within
inguin
lymph
node
induc
express
skin
home
molecul
sigmundsdottir
butcher
data
consist
observ
mucos
vaccin
infect
best
induc
b
cell
respons
mucosa
howev
mani
exampl
system
infect
induc
good
mucos
immun
also
parenter
given
vaccin
elicit
mucos
respons
recent
studi
provid
potenti
explan
observ
show
prime
cell
spleen
result
promiscu
home
program
drive
cell
intestin
mucosa
masopust
et
al
spleen
central
lymphoid
organ
directli
associ
particular
bodi
surfac
thu
make
teleolog
sens
cell
activ
spleen
promiscu
home
program
sampl
multipl
tissu
infect
interestingli
express
gut
home
receptor
transient
earli
effector
cell
spleen
could
migrat
gut
show
small
window
opportun
seed
mucosa
fig
happen
cell
migrat
gut
sever
studi
shown
cell
nt
recircul
memori
cell
blood
tissu
also
end
undergo
uniqu
differenti
program
driven
environ
tissu
fig
jameson
masopust
import
differ
system
mucos
immun
durat
memori
describ
earlier
section
review
well
document
system
memori
persist
extend
period
experiment
anim
human
true
memori
b
cell
also
antibodi
level
serum
maintain
longliv
plasma
cell
bone
marrow
contrast
durat
mucos
immun
rel
short
live
underli
mechan
wane
memori
mucos
site
well
understood
remain
one
challeng
question
vaccinolog
mani
critic
issu
need
address
effector
memori
cell
mucosa
turn
replenish
number
mediat
cytokin
period
reexposur
antigen
intermitot
lifespan
tissu
resid
memori
cell
molecul
necessari
surviv
lifespan
memori
b
cell
plasma
cell
mucos
site
mucos
plasma
cell
get
necessari
surviv
signal
nich
present
bone
marrow
recent
studi
suggest
attrit
previous
induc
immun
respons
gut
due
competit
ongo
respons
continu
gener
commens
flora
hapfelmei
et
al
answer
question
other
need
understand
memori
regul
mucosa
design
effect
vaccin
strategi
elicit
longterm
mucos
immun
jameson
masopust
multitud
express
vector
bacteri
viral
dna
develop
past
two
decad
consider
effort
gone
optim
use
vaccin
vector
see
articl
issu
liu
sever
studi
shown
boost
differ
vector
carri
antigen
better
enhanc
immun
respons
compar
boost
homolog
vector
heterolog
primeboost
approach
wide
use
effort
develop
vaccin
hiv
hcv
malaria
tb
see
articl
issu
although
promis
result
obtain
variou
heterolog
primeboost
vaccin
fundament
question
remain
unansw
briefli
address
two
key
question
first
optim
time
boost
second
effect
repeat
booster
shot
qualiti
immun
respons
determin
interv
first
immun
booster
shot
import
consid
differenti
pathway
memori
b
cell
memori
cell
high
prolif
potenti
form
sever
week
first
immun
gener
rule
better
interv
least
month
prime
boost
fig
boost
earli
give
suboptim
respons
similar
rule
appli
boost
antibodi
respons
sinc
memori
b
cell
go
germin
center
reaction
take
sever
month
develop
crotti
et
al
recent
studi
shown
repeat
boost
drive
memori
cell
toward
termin
differenti
wirth
et
al
good
gener
effector
memori
cell
also
drive
cell
mucosa
run
risk
deplet
popul
central
memori
cell
fig
howev
repeat
booster
shot
recruit
subset
previous
gener
memori
cell
result
heterogen
popul
memori
cell
variou
stage
differenti
fig
could
end
provid
right
balanc
cm
em
cell
summari
use
understand
memori
b
cell
differenti
possibl
optim
primeboost
strategi
order
develop
success
vaccin
pathogen
hiv
hcv
malaria
etc
essenti
vaccin
induc
neutral
antibodi
respons
also
gener
highli
effect
cell
immun
consider
effort
gone
develop
vaccin
regimen
induc
high
frequenc
memori
cell
minim
emphasi
develop
strategi
improv
function
qualiti
vaccineinduc
memori
cell
howev
appreci
target
appropri
innat
receptor
dc
possibl
modul
function
qualiti
memori
cell
see
articl
issu
coffman
et
al
innat
receptor
adjuv
inform
approach
recent
studi
identifi
addit
approach
use
drug
directli
act
cell
regul
memori
differenti
araki
et
al
pearc
et
al
rao
et
al
studi
show
mammalian
target
rapamycin
mtor
major
regul
memori
cell
differenti
memori
cell
qualiti
manipul
regul
mtor
pathway
vivo
administr
rapamycin
specif
inhibitor
mtor
vaccin
infect
mice
significantli
chang
fate
antigenspecif
cell
rapamycin
treatment
cell
expans
phase
increas
quantiti
memori
cell
promot
gener
memori
precursor
surviv
differenti
longliv
memori
cell
treatment
result
similar
number
antigenspecif
effector
cell
peak
clonal
expans
compar
untreat
mice
reduc
apoptot
cell
death
contract
phase
hand
inhibit
mtor
rapamycin
contract
phase
acceler
effector
memori
cell
transit
improv
qualiti
memori
cell
thu
target
mtor
pathway
enhanc
magnitud
also
qualiti
memori
cell
fig
use
drug
modul
memori
differenti
interest
new
approach
enhanc
vaccinemedi
immun
sinc
rapamycin
histor
use
immunosuppress
drug
obviou
safeti
concern
use
drug
vaccin
adjuv
howev
possibl
identifi
safer
drug
target
mtor
pathway
potenti
adjuv
enhanc
function
qualiti
memori
cell
mention
previou
section
success
vaccin
mostli
come
invari
pathogen
caus
acut
infect
follow
longterm
protect
immun
howev
sever
case
primari
infect
lead
protect
immun
case
variabl
pathogen
dengu
influenza
virus
memori
elicit
natur
infect
protect
homolog
viru
virus
differ
serotyp
green
rothman
halstead
subbarao
joseph
case
rapid
diversif
transmit
viru
make
immun
respons
ineffect
johnston
fauci
mcmichael
et
al
moir
fauci
pathogen
rsv
clearanc
infect
follow
protect
memori
sinc
reinfect
viru
occur
multipl
time
although
decreas
sever
ill
hall
final
pathogen
hcmv
ebv
tuberculosi
elimin
immun
respons
establish
life
long
carrier
state
equilibrium
reach
host
immun
respons
pathogen
persist
latent
dormant
state
reddehas
sacchettini
et
al
life
long
carrier
state
pose
risk
widespread
infect
individu
becom
immunosuppress
immunodefici
addit
hcmv
superinfect
alreadi
immun
donor
evad
cell
respons
process
complic
develop
prevent
vaccin
hansen
et
al
analysi
human
memori
cell
provid
novel
insight
develop
vaccin
pathogen
induc
partial
protect
nonprotect
nonsteril
immun
recent
studi
suggest
possibl
leverag
analysi
specif
class
human
memori
b
cell
identifi
conserv
epitop
protect
effector
mechan
repres
ration
basi
vaccin
design
discuss
methodolog
technic
approach
facilit
process
defin
analyt
vaccinolog
fig
concept
crossreact
protect
antigen
could
identifi
studi
antibodi
respons
initi
propos
context
hiv
vaccin
design
burton
idea
identifi
isol
broadli
neutral
antibodi
conserv
epitop
produc
immunogen
contain
epitop
immunodomin
form
approach
offer
advantag
focus
immun
respons
conserv
epitop
avoid
respons
variabl
site
mani
year
isol
monoclon
antibodi
repres
rate
limit
step
analysi
human
antibodi
respons
identif
target
antigen
conserv
epitop
last
year
sever
method
becom
avail
isol
high
effici
human
monoclon
antibodi
memori
b
cell
plasma
cell
approach
base
immort
total
memori
b
cell
follow
select
function
assay
traggiai
et
al
isol
antigenbind
memori
b
cell
total
plasma
cell
follow
rescu
specif
antibodi
singl
cell
pcr
express
heterolog
system
scheid
et
al
wrammert
et
al
use
method
becom
possibl
interrog
whole
repertoir
antibodi
made
immun
respons
maintain
memori
compart
approach
alreadi
provid
excit
result
identif
potent
broadli
neutral
antibodi
varieti
human
pathogen
common
theme
emerg
novel
studi
broadli
neutral
antibodi
exist
may
extrem
rare
extens
analysi
thousand
sera
infect
individu
led
identif
two
donor
novel
potent
broadli
neutral
monoclon
antibodi
isol
antibodi
identifi
highli
conserv
epitop
site
wu
et
al
well
conform
epitop
present
trimer
walker
et
al
anoth
relev
exampl
select
individu
memori
b
cell
make
antibodi
broadli
neutral
influenza
virus
corti
et
al
ekiert
et
al
antibodi
direct
conserv
epitop
stem
region
influenza
viru
hemagglutinin
protein
although
less
potent
classic
neutral
antibodi
direct
globular
head
neutral
vitro
vivo
virus
belong
differ
subtyp
base
notion
headless
hemagglutinin
vaccin
produc
shown
confer
broad
protect
anim
model
steel
et
al
human
monoclon
antibodi
high
neutral
activ
hcmv
isol
select
donor
use
map
conform
epitop
pentamer
complex
repres
candid
subunit
vaccin
macagno
et
al
human
antibodi
respons
dengu
viru
dissect
analysi
monoclon
antibodi
reveal
basic
mechan
neutral
infect
enhanc
beltramello
et
al
dejnirattisai
et
al
final
analysi
larg
number
human
monoclon
antibodi
hiv
reveal
role
polyreact
increas
appar
affin
antihiv
antibodi
heterolig
reveal
new
mechan
product
antibodi
pathogen
display
low
densiti
epitop
mouquet
et
al
besid
use
vaccin
design
human
monoclon
antibodi
find
direct
applic
passiv
vaccin
prophylact
therapeut
approach
develop
one
hundr
year
ago
fallen
short
limit
avail
immun
sera
casadeval
et
al
date
one
human
monoclon
antibodi
approv
prevent
rsv
infect
newborn
sever
fulli
human
antibodi
differ
stage
develop
prevent
treatment
variou
pathogen
toxin
identifi
potent
broadli
neutral
antibodi
could
use
either
singl
agent
cocktail
order
minim
select
escap
mutant
one
consid
vitro
neutral
assay
fulli
reflect
vivo
use
antibodi
sinc
may
critic
depend
effector
mechan
complementor
fc
receptormedi
kill
hessel
et
al
mozdzanowska
et
al
experiment
infect
mice
carri
human
fc
receptor
may
therefor
use
address
vivo
activ
human
monoclon
antibodi
nimmerjahn
ravetch
anoth
potenti
use
human
monoclon
antibodi
administr
togeth
vaccin
enhanc
modul
immun
respons
antibodi
increas
antigen
uptak
target
immunecomplex
fc
receptor
express
dc
lead
enhanc
antigen
present
mhc
class
ii
molecul
modul
epitop
present
simitsek
et
al
furthermor
antibodi
suppress
enhanc
b
cell
respons
target
antigen
sever
hundredfold
depend
isotyp
stoichiometri
heyman
thu
combin
antigen
antibodi
forese
converg
activ
passiv
vaccin
dissect
memori
cell
subset
rather
trivial
pursuit
reveal
fundament
aspect
immun
respons
relev
vaccin
design
discuss
intracellular
pathogen
extracellular
pathogen
parasit
elicit
effector
memori
cell
differ
function
properti
thu
import
vaccin
design
exploit
full
rang
effector
function
characterist
protect
respons
vaccin
made
attenu
pathogen
may
carri
pamp
elicit
damp
virul
pathogen
thu
may
abl
induc
type
respons
individu
antigen
taken
context
use
recombin
protein
insert
heterolog
vector
critic
requir
adjuv
capabl
elicit
appropri
type
immun
respons
two
experiment
approach
help
address
issu
high
throughput
interrog
memori
cell
ii
reconstruct
immun
respons
vitro
fig
sever
methodolog
avail
character
singl
cell
level
antigen
specif
cytokin
profil
home
receptor
function
properti
human
memori
cell
includ
polychromat
flow
cytometri
use
peptidehla
class
tetram
antibodi
surfac
molecul
cytokin
phosphoepitop
bolton
roeder
newel
et
al
perez
nolan
analysi
combin
global
gene
profil
provid
specif
signatur
immun
respons
berri
et
al
querec
et
al
altern
approach
suitabl
analysi
hla
class
ii
restrict
cell
respons
complex
antigen
even
whole
pathogen
limit
particular
hla
molecul
consist
screen
cell
librari
prepar
effector
memori
cell
subset
fig
approach
reveal
remark
compartment
pathogenspecif
memori
cell
individu
memori
subset
fs
unpublish
addit
analysi
memori
pool
tetram
cell
librari
use
also
interrog
repertoir
newel
et
al
taken
togeth
high
throughput
interrog
human
memori
cell
repertoir
offer
one
hand
possibl
predict
antigen
identifi
cell
epitop
complex
pathogen
gain
inform
class
cell
elicit
given
pathogen
thu
provid
two
critic
piec
inform
guid
cell
vaccin
design
ambiti
goal
current
reconstruct
vitro
b
cell
respons
pathogen
fig
although
may
eventu
requir
develop
organotyp
cultur
prime
cell
effect
achiev
cocultur
apc
pathogen
fs
christina
zielinski
unpublish
vitro
prime
experi
use
identifi
polar
cue
complex
pathogen
dissect
signal
mechan
cell
polar
may
help
defin
right
type
adjuv
use
cell
vaccin
mani
recent
advanc
understand
immun
system
parallel
develop
variou
vector
adjuv
set
stage
principl
immunolog
memori
use
ration
design
next
gener
vaccin
infecti
diseas
global
import
addit
also
possibl
learn
increas
understand
cell
dysfunct
chronic
viral
infect
tumor
develop
therapeut
vaccin
chronic
diseas
cancer
grow
consensu
immunolog
commun
three
urgent
need
new
initi
strengthen
research
human
system
davi
steinman
mellman
bridg
field
basic
immunolog
vaccin
research
among
establish
societi
dendrit
cell
vaccin
scienc
wwwdcvaccineorg
found
aim
promot
crossdisciplinari
approach
har
properti
innat
immun
system
design
new
vaccin
effector
cell
activ
lymphoid
tissu
transient
express
gut
home
receptor
migrat
intestin
mucosa
cell
undergo
distinct
memori
differenti
program
within
gut
recircul
memori
cell
tissu
tissu
resid
memori
cell
provid
first
line
defens
pathogen
initi
infect
intestin
mucosa
follow
primari
vaccin
cell
prolifer
differenti
effector
cell
major
effector
undergo
apoptosi
subset
differenti
form
pool
longliv
memori
cell
model
progress
memori
cell
differenti
character
gradual
acquisit
memori
cell
properti
abil
make
effect
prolif
respons
upon
reencount
antigen
b
base
memori
differenti
program
optim
time
boost
late
stage
effector
memori
transit
therefor
interv
month
recommend
prime
boost
antigen
specif
cell
respons
acut
infect
vaccin
expans
phase
cell
prolifer
becom
effector
cell
clearanc
pathogen
effector
cell
die
contract
phase
surviv
antigenspecif
cell
becom
memori
popul
b
without
rapamycin
treatment
c
rapamycin
improv
qualiti
quantiti
memori
cell
rapamycin
treatment
increas
memori
precursor
effector
cell
surviv
contract
phase
also
improv
qualiti
memori
cell
acceler
effector
memori
cell
format
first
second
line
adapt
immun
pathogen
second
line
antibodi
iga
igg
em
tissu
resid
memori
cell
site
pathogen
entri
gut
genitaltract
respiratori
tract
blood
etc
ye
immedi
delay
memori
cell
lympoid
tissu
respond
rapidli
compar
cell
howev
capac
immedi
protect
limit
delay
reach
site
infect
minim
moder
substanti
clonal
expans
differenti
effector
plasma
cell
migrat
multipl
tissu
includ
site
infect
